Annals of the Rheumatic Diseases, 0003-4967

Journal

1 - 10 out of 159Page size: 10

Publications

  1. 2020
  2. E-pub ahead of print

    Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids

    Adam Croft, Joana Campos, Amy Naylor, Angela Taylor, Myriam Chimen, Gareth Lavery, Karim Raza & Rowan Hardy, 8 Nov 2020, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

    Caroline Gordon, 25 Jun 2020, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter › peer-review

  4. Published

    SAT0186 Developing predictors of global BILAG treatment response in patients with Lupus Nephritis: more lessons from the Aspreva Lupus Management Study group (ALMS) data

    2 Jun 2020, In: Annals of the Rheumatic Diseases. 79, Suppl 1, p. 1034-1035 2 p.

    Research output: Contribution to journal › Abstract › peer-review

  5. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

    Caroline Gordon & 14 others, , Mar 2020, In: Annals of the Rheumatic Diseases. 79, 3, p. 356-362 7 p.

    Research output: Contribution to journal › Article › peer-review

  7. Accepted/In press

    Disruptive Innovation in Rheumatology; New Networks of Global Public-Private Partnerships are Needed to Take Advantage of Scientific Progress

    Christopher Buckley, 26 Feb 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases. 79, 5

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

    Raymond Oppong, Sue Jowett, Feb 2020, In: Annals of the Rheumatic Diseases. 79, 2, p. 276-284 9 p.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

    Benjamin Fisher & 2 others, Simon Bowman, Jan 2020, In: Annals of the Rheumatic Diseases. 79, 1, p. 3-18 16 p., 216114.

    Research output: Contribution to journal › Article › peer-review

  10. 2019
  11. Published

    Urine metabolic profile in rheumatoid arthritis development

    Stephen Young, 27 Jun 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 2129-2130 2 p.

    Research output: Contribution to journal › Abstract › peer-review

  12. Published

    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Caroline Gordon, 29 Mar 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 736-745 10 p.

    Research output: Contribution to journal › Review article › peer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next